{"symbol": "AFMD", "companyName": "Affimed N.V.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.affimed.com", "description": "Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology to fight tumor cells.", "CEO": "Adi Hoess", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}